|
Volumn 28, Issue , 2014, Pages
|
The current clinical value of the DCIS Score
a a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GENETIC MARKER;
TUMOR MARKER;
ADJUVANT THERAPY;
BREAST NEOPLASMS;
CARCINOMA, INTRADUCTAL, NONINFILTRATING;
DECISION SUPPORT SYSTEM;
DISEASE FREE SURVIVAL;
FEMALE;
GENETIC MARKER;
GENETIC PREDISPOSITION;
GENETIC SCREENING;
GENETICS;
HUMAN;
MASTECTOMY;
MORTALITY;
PATHOLOGY;
PATIENT SELECTION;
PERSONALIZED MEDICINE;
PHENOTYPE;
PREDICTIVE VALUE;
RISK ASSESSMENT;
RISK FACTOR;
SECONDARY;
TIME;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
BREAST NEOPLASMS;
CARCINOMA, INTRADUCTAL, NONINFILTRATING;
DECISION SUPPORT TECHNIQUES;
DISEASE-FREE SURVIVAL;
FEMALE;
GENETIC MARKERS;
GENETIC PREDISPOSITION TO DISEASE;
GENETIC TESTING;
HUMANS;
INDIVIDUALIZED MEDICINE;
MASTECTOMY;
NEOPLASM RECURRENCE, LOCAL;
PATIENT SELECTION;
PHENOTYPE;
PREDICTIVE VALUE OF TESTS;
RADIOTHERAPY, ADJUVANT;
RISK ASSESSMENT;
RISK FACTORS;
TIME FACTORS;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 84921850525
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (8)
|
References (0)
|